1)Burde RM, Savino PJ, Trobe JD:Optic Neuropathies. In Burde RM, et al, editors:Clinical Decisions in Neuro-Ophthalmology. 3rd ed. 27-40, Mosby, St. Louis, 2002
2)Optic Neuritis Study Group:High-and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis. Arch Ophthalmol 121:944-949, 2003
3)Beck RW, Cleary PA, Anderson MM Jr et al:A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Eng J Med 326:581-588, 1992
4)PRISMS(Preventionof Relapses and Disability by Interferon Beta-1a Subcutaneously in Multiple Sclerosis)Study Group:Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 352:1498-1504, 1998
5)Lennon VA, Kryzer TJ, Pittock SJ et al:IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473-477, 2005
6)Trobe JD:Optic nerve and chiasmⅡ:Neoplasmic, aneurysmal disorders.:The neurology of vision. 240-256, Oxford University Press, Oxford, 2001
7)中村 誠:視神経周囲炎.中馬秀樹(編):眼科診療クオリファイ7(視神経疾患のすべて).57-60,中山書店,東京,2011
8)Posner JB:Neurologic Complication of Cancer. FA Davis, Philadelphia, 1995
9)Brodsky MC:Congenital optic disc anomalies. Pediatric Neuro-Ophthalmology, 2nd ed. 59-96, Springer, 2010
10)清水優子:NMOの頭部MRIからみた臨床像の特徴.BRAIN and NERVE 62:933-943,2010